Intensive Care Medicine Department, Lapeyronie Hospital, Montpellier, France; PhyMedExp, INSERM, CNRS, Montpellier, France.
Department of Internal Medicine 2, E3M Institute, Paris, France; Medical Intensive Care Unit, Institute of Cardiology, La Pitie-Salpetriere Hospital, University of Paris 6, Paris, France.
Chest. 2020 Sep;158(3):1017-1026. doi: 10.1016/j.chest.2020.03.050. Epub 2020 Apr 11.
Critically ill patients with systemic rheumatic disease (SRD) have benefited from better provision of rheumatic and critical care in recent years. Recent comprehensive data regarding in-hospital mortality rates and, most importantly, long-term outcomes are scarce.
The aim of this study was to assess short and long-term outcome of patients with SRD who were admitted to the ICU.
All records of patients with SRD who were admitted to ICU between 2006 and 2016 were reviewed. In-hospital and one-year mortality rates were assessed, and predictive factors of death were identified.
A total of 525 patients with SRD were included. Causes of admission were most frequently shock (40.8%) and acute respiratory failure (31.8%). Main diagnoses were infection (39%) and SRD flare-up (35%). In-hospital and one-year mortality rates were 30.5% and 37.7%, respectively. Predictive factors that were associated with in-hospital and one-year mortalities were, respectively, age, prior corticosteroid therapy, simplified acute physiology score II ≥50, need for invasive mechanical ventilation, or need for renal replacement therapy. Knaus scale C or D and prior conventional disease modifying antirheumatic drug therapy was associated independently with death one-year after ICU admission.
Critically ill patients with SRD had a fair outcome after an ICU stay. Increased age, prior corticosteroid therapy, and severity of critical illness were associated significantly with short- and long-term mortality rates. The one-year mortality rate was also associated with prior health status and conventional disease modifying antirheumatic drug therapy.
近年来,患有系统性风湿病(SRD)的危重症患者通过更好地提供风湿病和重症护理而受益。最近有关住院死亡率的数据很全面,最重要的是长期预后数据却很缺乏。
本研究旨在评估入住 ICU 的 SRD 患者的短期和长期预后。
回顾了 2006 年至 2016 年期间入住 ICU 的 SRD 患者的所有记录。评估了住院和 1 年死亡率,并确定了死亡的预测因素。
共纳入了 525 例 SRD 患者。导致入院的主要原因是休克(40.8%)和急性呼吸衰竭(31.8%)。主要诊断为感染(39%)和 SRD 发作(35%)。住院和 1 年死亡率分别为 30.5%和 37.7%。与住院和 1 年死亡率相关的预测因素分别为年龄、皮质类固醇治疗史、简化急性生理学评分 II≥50、需要有创机械通气或需要肾脏替代治疗。Knaus 分级 C 或 D 和常规疾病修饰抗风湿药物治疗史与入住 ICU 1 年后的死亡独立相关。
入住 ICU 的 SRD 患者预后尚可。年龄增加、皮质类固醇治疗史和危重症严重程度与短期和长期死亡率显著相关。1 年死亡率还与既往健康状况和常规疾病修饰抗风湿药物治疗相关。